首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1463561

歐洲體外診斷市場預測至 2030 年 - 區域分析 - 按產品和服務、技術、應用和最終用戶

Europe In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

出版日期: 2024年01月24日 | 出版商:

The Insight Partners | 英文 124 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

歐洲體外診斷市場預計將從2022年的226.1655億美元成長到2030年的342.4712億CAGR。

COVID-19 大流行期間體外診斷需求的成長推動了歐洲體外診斷市場

用於診斷傳染病的 IVD 包括免疫測定和分子測定。診斷公司也致力於快速改進其管理 COVID-19 的產品。此外，監管機構對其標準進行了臨時修訂或修改，這有利於在大流行期間推出新的體外診斷設備。由於這些政府舉措，對分子診斷和免疫測定的需求激增。此外，許多公司也擴大了 IVD 製造的產品線。

2021年6月，英國體外診斷協會（BIVDA）啟動「數位革命」策略，鼓勵在COVID-19大流行期間體外診斷取得突破。 2022 年 7 月，BioGX 宣佈在其 Pixel 平台上推出帶有 CE 標誌的三基因即時護理 (POC) 多重 COVID-19 測試。因此，由於對即時診斷 (POC) 診斷和實驗室檢測程序的需求不斷成長，COVID-19 大流行使體外診斷市場受益。

歐洲體外診斷市場概況

歐洲體外診斷市場已細分為德國、法國、英國、義大利、西班牙和歐洲其他地區。該地區的市場成長歸因於疾病診斷意識的提高、人口老化的加劇以及體外診斷技術的進步，從而主導了整體市場的成長。德國佔據歐洲體外診斷（IVD）市場的最大佔有率。德國IVD產業以其創新能力而聞名。其 IVD 產業受益於分子生物學、小型化和自動化的發展。德國的「工業4.0」計畫正在經歷數位化，特別是在ICD領域，「實驗室4.0」是為資料處理、基於雲端的IT解決方案、實驗室和生產自動化流程以及數位網路而開發的。

在 COVID-19 大流行期間，德國 IVD 市場的需求大幅成長。全面檢測是德國政府對抗疫情和保護民眾免受感染的衛生政策策略的核心組成部分。總部位於德國的公司在開發分子測試以及用於分子資訊生物分析的高科技儀器和耗材方面是公認的創新者。擁有實驗室自動化系統的公司透過推出創新產品來發展體外診斷，推動了德國體外診斷市場的發展。

歐洲體外診斷市場收入及 2030 年預測（百萬美元）

歐洲體外診斷市場細分

歐洲體外診斷市場分為產品和服務、技術、應用、最終用戶和國家。

根據產品和服務，歐洲體外診斷市場分為試劑和試劑盒、儀器以及軟體和服務。 2022年，試劑和試劑盒細分市場在歐洲體外診斷市場中佔據最大佔有率。

根據技術，歐洲體外診斷市場分為免疫測定/免疫化學、臨床化學、分子診斷、微生物學、血糖自我監測、凝血和止血、血液學、尿液分析等。 2022 年，免疫分析/免疫化學領域在歐洲體外診斷市場中佔據最大佔有率。

根據應用，歐洲體外診斷市場分為傳染病、糖尿病、腫瘤學、心臟病學、自體免疫疾病、腎臟病學等。 2022年，傳染病領域在歐洲體外診斷市場中佔據最大佔有率。

根據最終用戶，歐洲體外診斷市場分為醫院、實驗室、家庭護理等。 2022 年，醫院細分市場在歐洲體外診斷市場中佔據最大佔有率。

根據國家/地區，歐洲體外診斷市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。 2022 年，歐洲其他地區將主導歐洲體外診斷市場。

Abbott Laboratories、Becton Dickinson and Co、bioMerieux SA、Bio-Rad Laboratories Inc、Danaher Corp、F. Hoffmann-La Roche Ltd、Qiagen NV、Siemens AG、Sysmex Corp 和Thermo Fisher Scientific Inc 是在這些地區營運的一些領先公司。

IVDs that are used in the diagnosis of infectious diseases include immunoassays, and molecular assays. Diagnostics companies also focus on making rapid advancements in their offerings to manage COVID-19. Further, regulatory authorities introduced temporary amendments or modifications to their standards, which favored the launches of new IVDs during the pandemic. The demand for molecular diagnostics and immunoassays surged due to these government initiatives. Moreover, many companies expanded their product lines for IVD manufacturing.

In June 2021, the British In Vitro Diagnostics Association (BIVDA) launched "The Digital Revolution" strategy to encourage breakthroughs in in-vitro diagnostics during the COVID-19 pandemic. In July 2022, BioGX announced the launch of a CE-marked, three-gene point-of-care (POC) multiplex COVID-19 test on its Pixel platform. Thus, the COVID-19 pandemic has benefitted the in-vitro diagnostics market due to the rising demand for point-of-care (POC) diagnostics and laboratory testing procedures.

Europe In-Vitro Diagnostics Market Overview

The Europe in-vitro diagnostics market has been segmented into Germany, France, UK, Italy, Spain, and the Rest of Europe. The market growth in this region is attributed to the rising awareness of the disease diagnosis, increasing ageing population, and technological advancements in in-vitro diagnostics thereby dominating the overall market growth. Germany accounts for the largest share of the in-vitro diagnostic (IVD) market in Europe. The German IVD industry is known for its innovation capabilities. Its IVD industry benefits from developments in molecular biology, miniaturization, and automation. The German "Industrie 4.0" project is undergoing digitalization, particularly in ICD, with "Lab 4.0" developed for data handling, cloud-based IT solutions, lab and production automation processes, and digital networking.

The IVD market in Germany experienced an enormous rise in demand amid the COVID-19 pandemic. Comprehensive testing was a central component of the German government's health policy strategy to combat the pandemic and protect the population from infection. Companies based in Germany are proven innovators in developing molecular tests as well as high-tech instruments and consumables that are used in the bioanalysis of molecular information. Developments of in-vitro diagnostics through innovative product launches by companies with automation systems in labs boost the in-vitro diagnostics market in Germany.

Europe In-Vitro Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe In-Vitro Diagnostics Market Segmentation

The Europe in-vitro diagnostics market is segmented into product & services, technology, application, end user, and country.

Based on product & services, the Europe in-vitro diagnostics market is segmented into reagents & kits, instruments, and software & services. The reagents & kits segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on technology, the Europe in-vitro diagnostics market is segmented into immunoassay/ immunochemistry, clinical chemistry, molecular diagnostics, microbiology, blood glucose self-monitoring, coagulation & hemostasis, hematology, urinalysis, and others. The immunoassay/ immunochemistry segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on application, the Europe in-vitro diagnostics market is segmented into infectious diseases, diabetes, oncology, cardiology, autoimmune diseases, nephrology, and others. The infectious diseases segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on end user, the Europe in-vitro diagnostics market is segmented into hospitals, laboratories, homecare, and others. The hospitals segment held the largest share of the Europe in-vitro diagnostics market in 2022.

Based on country, the Europe in-vitro diagnostics market is segmented int o Germany, France, UK, Italy, Spain, and the Rest of Europe. The Rest of Europe dominated the Europe in-vitro diagnostics market in 2022.

Abbott Laboratories, Becton Dickinson and Co, bioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Qiagen NV, Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe in-vitro diagnostics market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe In-Vitro Diagnostics Market - Key Industry Dynamics

4.1 Key Market Drivers
- 4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
- 4.1.2 Surge in Demand for In-Vitro Diagnostics During COVID-19 Pandemic
4.2 Market Restraint
- 4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
4.3 Market Opportunities
- 4.3.1 Integration of IVD with Digital Health Technologies
4.4 Future Trends
- 4.4.1 Increasing Demand for Personalized Medicine and Genomics

5. In-Vitro Diagnostics Market - Europe Market Analysis

5.1 Europe In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

6.1 Overview
6.2 Europe In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
6.3 Reagents and Kits
- 6.3.1 Overview
- 6.3.2 Reagents and Kits: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Software and Services
- 6.4.1 Overview
- 6.4.2 Software and Services: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Instruments
- 6.5.1 Overview
- 6.5.2 Instruments: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology

7.1 Overview
7.2 Europe In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Immunoassay/ Immunochemistry
- 7.3.1 Overview
- 7.3.2 Immunoassay/ Immunochemistry: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Clinical Chemistry
- 7.4.1 Overview
- 7.4.2 Clinical Chemistry: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Molecular Diagnostics
- 7.5.1 Overview
- 7.5.2 Molecular Diagnostics: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Microbiology
- 7.6.1 Overview
- 7.6.2 Microbiology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Blood Glucose Self-Monitoring
- 7.7.1 Overview
- 7.7.2 Blood Glucose Self-Monitoring: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Coagulation and Hemostasis
- 7.8.1 Overview
- 7.8.2 Coagulation and Hemostasis: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.9 Hematology
- 7.9.1 Overview
- 7.9.2 Hematology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.10 Urinalysis
- 7.10.1 Overview
- 7.10.2 Urinalysis: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.11 Others
- 7.11.1 Overview
- 7.11.2 Others: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Europe In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Infectious Disease
- 8.3.1 Overview
- 8.3.2 Infectious Diseases: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Diabetes
- 8.4.1 Overview
- 8.4.2 Diabetes: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Oncology
- 8.5.1 Overview
- 8.5.2 Oncology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
- 8.6.1 Overview
- 8.6.2 Cardiology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Autoimmune Diseases
- 8.7.1 Overview
- 8.7.2 Autoimmune Diseases: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Nephrology
- 8.8.1 Overview
- 8.8.2 Nephrology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Others
- 8.9.1 Overview
- 8.9.2 Others: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Europe In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratories
- 9.4.1 Overview
- 9.4.2 Laboratories: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis

10.1 Europe In-Vitro Diagnostics Market
- 10.1.1 Overview
- 10.1.2 Europe In-Vitro Diagnostics Market, by Country
  - 10.1.2.1 Germany: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Germany: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.3 Germany: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.1.4 Germany: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.1.5 Germany: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.6 Germany: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.2 France: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 France: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.3 France: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.2.4 France: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.2.5 France: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.6 France: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.3 UK: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 UK: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.3 UK: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.3.4 UK: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.3.5 UK: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.6 UK: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.4 Italy: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Italy: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.3 Italy: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.4.4 Italy: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.4.5 Italy: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.4.6 Italy: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.5 Spain: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Spain: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.3 Spain: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.5.4 Spain: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.5.5 Spain: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.5.6 Spain: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.6 Rest of Europe: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Europe In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Europe In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Europe In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.6.6 Rest of Europe: Europe In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)

11. Industry Landscape

11.1 Organic Developments
- 11.1.1 Overview
11.2 Inorganic Developments
- 11.2.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Danaher Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Siemens AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Sysmex Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Becton Dickinson and Co
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 bioMerieux SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Qiagen NV
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe In-Vitro Diagnostics Market Segmentation
Table 2. Germany Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. France Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. France Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 8. France Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 9. France Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. UK Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. UK Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 12. UK Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. UK Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Italy Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. Italy Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Spain Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Europe In-Vitro Diagnostics Market, by Product and Services - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe In-Vitro Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe In-Vitro Diagnostics Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Europe In-Vitro Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Organic Developments Done by Companies
Table 27. Inorganic Developments Done by Companies
Table 28. Glossary of Terms, Europe In-Vitro Diagnostics Market

List Of Figures

Figure 1. Europe In-Vitro Diagnostics Market Segmentation, By Country
Figure 2. Europe In-Vitro Diagnostics Market: Key Industry Dynamics
Figure 3. Europe In-Vitro Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe In-Vitro Diagnostics Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Europe In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
Figure 6. Reagents and Kits: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Software and Services: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Instruments: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 10. Immunoassay/ Immunochemistry: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Clinical Chemistry: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular Diagnostics: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Microbiology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Blood Glucose Self-Monitoring: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Coagulation and Hemostasis: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Hematology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Urinalysis: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
Figure 20. Infectious Diseases: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Diabetes: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Oncology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Cardiology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Autoimmune Diseases: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Nephrology: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
Figure 28. Hospitals: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Laboratories: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Homecare: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Europe In-Vitro Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 33. Europe In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 34. Germany: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. France: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 36. UK: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 37. Italy: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 38. Spain: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 39. Rest of Europe: Europe In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)